SFA Therapeutics

SFA Therapeutics is a biotechnology company focused on developing innovative therapies for chronic inflammatory diseases, with a particular emphasis on psoriasis. Their lead product, SFA-002, is a next-generation oral immune tolerance therapy designed to restore immune function by targeting the underlying immune dysfunction associated with psoriasis, rather than broadly suppressing the immune system. This investigational therapy is a deuterated short-chain fatty acid formulated for once-daily dosing, which aims to reset immunity through the gut-immune axis, a critical pathway in immune regulat…